Dysregulation of hepatic and lipoprotein metabolism in the atherogenic dyslipidemia
EAS Academy. Taskinen M. May 7, 2018; 217750
Prof. Marja-Riitta Taskinen
Prof. Marja-Riitta Taskinen

Access to Premium Content is a benefit of Individual EAS membership. Apply for membership


Access EAS content "anytime, anywhere" with the EAS Academy App for iOS and Android


For any questions contact us at office@eas-society.org

Abstract
Discussion Forum (0)
Rate & Comment (0)

FEATURED OPEN LECTURE MARCH-APRIL 2019
Dysregulation of hepatic and lipoprotein metabolism in the atherogenic dyslipidemia




Professor Marja-Riitta Taskinen, Helsinki, Finland.
This lecture is from the 86th EAS Congress, 2018.
                                                                                                                         
One of the founders of clinical lipidology, the American Professor Richard Havel, used to claim atherosclerosis is a liver disease. This notion underlies the importance of hepatic function for multiple metabolic pathways. Concerning atherogenesis, lipid and lipoprotein metabolism seems crucial and its regulation at the hepatocyte level is better and better understood. In her excellent talk, professor Marja-Riitta Taskinen overviews the recent findings of kinetic studies as well as of very interesting dietary experiments showing profound and rapid changes of hepatic and intestinal lipoprotein production in response to dietary change.

Free access to the lecture will be open until May 07, 2019.
Code of conduct/disclaimer available in General Terms & Conditions

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies